首页|氯胍介导氧化还原驱动的铁死亡诱导膀胱癌细胞凋亡的研究

氯胍介导氧化还原驱动的铁死亡诱导膀胱癌细胞凋亡的研究

扫码查看
目的 探讨氯胍对膀胱癌细胞增殖、凋亡影响的潜在作用机制.方法 将253J细胞随机分为对照组(正常培养)、氯胍组(42.06 μmol·L-1氯胍)、pcDNA组(转染pcDNA+42.06 μmol·L-1氯胍)、FADS2组[转染脂肪酸去饱和酶基因 2(FADS2)+42.06 μmol·L-1 氯胍]、si-NC 组(转染 si-NC)、si-FADS2组(转染 si-FADS2)、Ferrostatin-1 组(转染 si-FADS2+10 μmol·L-1铁抑素-1).用实时荧光定量聚合酶链反应(RT-qPCR)实验检测相关基因相对表达水平,用蛋白质印迹实验检测各蛋白相对表达水平,用原位末端转移酶标记法(Tunel)实验检测细胞凋亡情况,用5-乙炔基-2'-脱氧尿苷(EdU)实验检测细胞增殖情况,用Transwell实验检测细胞迁移能力,用试剂盒法测定Fe2+水平,用DCFH-DA探针检测活性氧(ROS)水平.结果 对照组、氯胍组、pcDNA 组、FADS2 组细胞 FADS2 mRNA 水平分别为 1.00±0.11、0.47±0.09、0.49±0.06 和 2.09±0.21,细胞增殖率分别为(100.00±3.50)%、(54.31±4.90)%、(56.46±5.17)%和(78.76±6.50)%,凋亡率分别为(3.92±0.53)%、(28.79±3.30)%、(27.20±2.90)%和(7.34±0.68)%,细胞迁移数分别为(132.70±9.81)、(70.10±5.05)、(68.70±5.37)和(101.80±11.25)个,Fe2+水平分别为(100.00±8.14)%、(201.33±17.84)%、(192.38±21.34)%和(116.70±10.90)%,谷胱甘肽过氧化物酶 4(GPX4)蛋白相对表达水平分别为 0.77±0.05、0.31±0.05、0.34±0.05 和0.68±0.06.氯胍组的上述指标分别与对照组比较,FADS2组的上述指标分别与pcDNA组比较,在统计学上差异均有统计学意义(均P<0.05).si-NC组、si-FADS2组、Ferrostatin-1 组 ROS 水平分别为9.72±1.18、40.94±5.63 和 13.77±1.40.si-FADS2组与si-NC组比较,Ferrostatin-1组与si-FADS2比较,在统计学上差异均有统计学意义(均P<0.05).结论 氯胍可通过抑制FADS2表达介导氧化还原驱动的铁死亡途径诱导膀胱癌细胞凋亡.
Proguanil induces bladder cancer cell apoptosis through mediating oxidation-reduction driven ferroptosis
Objective To explore the potential mechanism of proguanil on the proliferation and apoptosis of bladder cancer cells.Methods 253J cells were randomly divided into control group(normal treatment),proguanil group(42.06 μmol·L-1 proguanil),pcDNA group(transfected with pcDNA+42.06 μmol·L-1 proguanil),FADS2 group[transfected fatty acid desaturase gene 2(FADS2)+42.06 μmol·L-1 proguanil],si-NC(transfection si-NC),si-FADS2(transfection si-FADS2),Ferrostatin-1 group(transfected with si-FADS2+10 μmol·L-1 ferrostatin-1).Real-time fluorescence quantitative polymerase chain reaction(RT-qPCR)assay was used to detect mRNA expression of related genes;Western blot assay was used to detect the expression of each protein;apoptosis was detected by TdT mediated dUDP nick end labeling(Tunel)assay;5-ethynyl-2'-deoxyuridine(EdU)assay to detect cell proliferation;the Transwell assay measures the ability of cells to migrate;Fe2+levels were determined by kit method;DCFH-DA probe was used to detect ROS levels.Results The mRNA levels of FADS2 in control group,proguanil group,pcDNA group and FADS2 group were 1.00±0.11,0.47±0.09,0.49±0.06 and 2.09±0.21,respectively;cell proliferation rate were(100.00±3.50)%,(54.31±4.90)%,(56.46±5.17)%and(78.76±6.50)%,respectively;the apoptosis rate were(3.92±0.53)%,(28.79±3.30)%,(27.20±2.90)%and(7.34±0.68)%,respectively;the migration number were 132.70±9.81,70.10±5.05,68.70±537 and 101.80±11.25,respectively;Fe2+level were(100.00±8.14)%,(201.33±17.84)%,(192.38±21.34)%and(116.70±10.90)%,respectively;GPX4 protein relative expression level were 0.77±0.05,0.31±0.05,0.34±0.05 and 0.68±0.06,respectively.The above indexes in proguanil group were compared with those in control group,the above indexes in FADS2 group were compared with those in pcDNA group,all the differences were statistically significant(all P<0.05).The ROS levels of si-NC,si-FADS2 and Ferrostatin-1 groups were 9.72±1.18,40.94±5.63 and 13.77±1.40,respectively.Compared the si-FADS2 group with the si-NC group,Ferrostatin-1 group compared with si-FADS2 group,ROS level were significantly different(all P<0.05).Conclusion Proguanil can induce the apoptosis of bladder cancer cells by inhibiting FADS2 expression mediated by oxidation-reduction driven ferroptosis pathway.

bladder cancerproguanilfatty acid desaturase gene 2ferroptosisapoptosis

潘清华、刘印龙、刘勇、廖宝春、胡健、朱志坚

展开 >

赣州市肿瘤医院(赣南医科大学附属肿瘤医院)腹盆部肿瘤内科,江西赣州 341000

赣州市肿瘤医院(赣南医科大学附属肿瘤医院)腹部外科,江西赣州 341000

赣州市肿瘤医院(赣南医科大学附属肿瘤医院)药学部,江西赣州 341000

氯胍 膀胱癌 脂肪酸去饱和酶基因2 铁死亡 凋亡

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(20)